| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/11/1997 | US5602149 1-OXO-2-(phenylsulphonylamino)pentypiperidine derivatives, their preparation and their therapeutic application |
| 02/11/1997 | US5602122 Method for lowering total serum cholesterol and treating hypercholesterolemia with aminoacetylmercapto derivatives |
| 02/11/1997 | US5602116 Administering vitamin d analog |
| 02/11/1997 | US5602109 Feeding human infant dietary formula that alleviates diarrhea; contains ribonucleotides |
| 02/11/1997 | US5602105 Cardiotropic formulation |
| 02/11/1997 | US5602101 Antithrombotic agents |
| 02/11/1997 | US5602100 Analgesics, treating gastrointestinal disorders |
| 02/11/1997 | US5602099 δ opioid receptor antagonists |
| 02/11/1997 | US5602098 Anticancer agent |
| 02/11/1997 | US5602097 Synthetic antibiotics |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602094 Treatment of tumors |
| 02/11/1997 | US5602033 Coccidiosis vaccine |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602007 Recombinant DNA molecules |
| 02/11/1997 | US5602005 Antigen remains associated with primate sperm after acrosome reaction |
| 02/11/1997 | US5601990 Methods of diagnosing colorectal tumors and metastasis thereof |
| 02/11/1997 | US5601981 Methods for determining and agents for modulating cellular redox potential and genotoxic states |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601830 Staphylococcus aureus enterotoxin H and methods of use |
| 02/11/1997 | US5601828 CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601823 Avian antitoxins to clostridium difficle toxin A |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601819 Bispecific monoclonal antibody having common fc portion, first fab portion specific for cd3, second fab portion specific for interleukin-2 receptor, cd28, cd45 or cdtfr |
| 02/11/1997 | US5601815 Coadministering to the mammal an effective dose of each of interleukin-4 and 10 |
| 02/11/1997 | US5601814 Use of IL-6 to treat toxic shock |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/11/1997 | CA2045605C Treatment of leukocyte dysfunction with gm-csf |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004115A2 Method for producing haemin proteins using plant cells, resulting proteins and products containing same |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004104A2 Tumor type ii hexokinase transcription regulatory regions |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004091A1 Novel receptor ligands and genetic sequences encoding same |
| 02/06/1997 | WO1997004090A1 SEQUENCE AND EXPRESSION OF Sox-18 |
| 02/06/1997 | WO1997004087A1 Ribozymes for the selective inhibition of expression by mhc allele genes, and drugs containing such ribozymes |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997004080A1 Novel protein and monoclonal antibody specific thereto |
| 02/06/1997 | WO1997004075A1 Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods |
| 02/06/1997 | WO1997004009A1 Colostrum derived growth factor |
| 02/06/1997 | WO1997004008A1 Anti-fungal peptides |
| 02/06/1997 | WO1997004007A2 Metal-containing ribonucleotide polypeptides |
| 02/06/1997 | WO1997004006A1 Substance for use against tumour growth and viral infections |
| 02/06/1997 | WO1997004005A2 Cyclosporin derivatives with anti-hiv effect |
| 02/06/1997 | WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003997A1 Anti-viral guanosine-rich oligonucleotides |
| 02/06/1997 | WO1997003995A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003700A2 Gamma-interferon activity modulating agent |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003694A1 Remedy for viral diseases |
| 02/06/1997 | WO1997003693A1 Type ii phospholipase a2 and its use in killing gram-positive bacteria |
| 02/06/1997 | WO1997003692A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions |
| 02/06/1997 | WO1997003691A1 Methods of treatment of neurological diseases by interferon antagonists |
| 02/06/1997 | WO1997003690A1 Treatment of acute leukemia with interleukin-10 |
| 02/06/1997 | WO1997003689A1 Method of treating epilepsy with brain derived neurotrophic factor |
| 02/06/1997 | WO1997003688A1 Pharmaceutical compositions containing protein |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003686A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | WO1997003684A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 02/06/1997 | WO1997003682A1 Method for treating cancers using 6-[3-[1-adamantyl]-4-hydroxyphenyl] |
| 02/06/1997 | WO1997003680A1 Transferrin glycans composition for the induction of immune tolerance |
| 02/06/1997 | WO1997003679A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/06/1997 | WO1997003676A1 Novel pharmaceutical formulation of dehydroepiandrosterone for percutaneous topical application |
| 02/06/1997 | WO1997003668A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 02/06/1997 | WO1996040926A3 Detection of cryptosporidium parvum |
| 02/06/1997 | WO1996040770A3 Anti-fungal d-amino acid histatin-based peptides |
| 02/06/1997 | WO1996040760A3 Iodine-containing peptides and their use as x-ray contrast media |
| 02/06/1997 | WO1996040074A3 Device for releasing aggregation-stabilized, biologically active agent |
| 02/06/1997 | WO1996039501A3 Oligonucleotides specific for human papillomavirus |
| 02/06/1997 | WO1996036314A3 Method for drug delivery to the pulmonary system |
| 02/06/1997 | WO1996035415A3 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 02/06/1997 | WO1996028214A3 Treatment of pulmonary hypertension with a bombesin antagonist |
| 02/06/1997 | DE19540515C1 Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten Tumor therapy by adoptive transfer CD44v-specific cytotoxic T lymphocytes |
| 02/06/1997 | DE19528544A1 cDNA-Sequenz und daraus abgeleitete Aminosäuresequenz des Vorläuferproteins von humanem GCAP II/Uroguanylin sowie Aminosäuresequenz des im humanen Blut zirkulierenden Fragmentes cDNA sequence and deduced amino acid sequence of the precursor protein of human GCAP II / uroguanylin and amino acid sequence of the human blood circulating in the fragment |
| 02/06/1997 | CA2227867A1 Anti-viral guanosine-rich oligonucleotides |
| 02/06/1997 | CA2227592A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227292A1 Anti-fungal peptides |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases |
| 02/06/1997 | CA2227193A1 P16 expression constructs and their application in cancer therapy |
| 02/06/1997 | CA2227136A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2226911A1 Methods of treatment of neurological diseases by interferon antagonists |